From the moment you will walk in, you will feel like more than just a patientyou will feel understood
Exenatide (Byetta) was approved in 2005 and is administered as a subcutaneous injection twice daily, taken within 60 minutes before morning and evening meals
Extracted variables encompassed four domains: (1) study characteristics, including first author, publication year, country, study design, and follow-up duration
Trust us to help you achieve a fresh start and the confidence to define your own journey
This approach isnt about masking symptoms or pushing through discomfort
For patients experiencing tirzepatide-related sleep disruption, adjusting injection timing (morning versus evening), ensuring adequate hydration, and addressing any medication-related anxiety can help restore normal sleep patterns